Better Coronavirus Stock: Opko Health or BioNTech?
With more than 39 million confirmed COVID-19 cases and upwards of 1.1 million deaths from the coronavirus worldwide, the pandemic continues to dominate attention. For investors who want to seek profits among companies fighting back against the coronavirus, there are a host of options — some investigating potential treatments, others developing vaccines, still more providing diagnostic testing.
With so many coronavirus stocks to choose from, I recommend limiting your consideration to those with the strongest momentum. Two such companies are the biotechs Opko Health (NASDAQ: OPK) and BioNTech (NASDAQ: BNTX).
Image Source: Getty Images.